Recent Updates
Recently added Catalysts
CELC Positive Sentiment

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

Wednesday, August 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celcuity Inc. has announced its schedule for the release of financial results for the second quarter of 2024, set to take place after market close on August 14, 2024. The company will also host a webcast and conference call at 4:30 p.m. Eastern Time on the same day to discuss the results and offer a corporate update. This event underscores Celcuity's commitment to communication with its stakeholders and highlights its ongoing developments in targeted therapies for oncology.
Price reaction · baseline $16.29 (2024-08-06 close) · hit after-hours · clean, no other CELC news in the window
day 0 close
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Celcuity is scheduled to release its financial results, indicating transparency.
  • Management will host a webcast to discuss results, providing stakeholders an update.
  • Focusing on targeted therapies for oncology suggests innovation in treatment options.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
14.9%
average across 6 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
Gedatolisib
Phase 3 · Breast Cancer

Full Press Release Details

MINNEAPOLIS, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, August 14, 2024. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink: https://viavid.webcasts.com/starthere.jsp?ei=1678191&tp_key=c55c86e8c3. A replay of the webcast will be available on the Celcuity website following the live event.
View source version of release on GlobeNewswire.com

Frequently Asked Questions

When will Celcuity release its Q2 2024 financial results?

Celcuity will announce its Q2 2024 financial results on August 14, 2024.

What time is the webcast about Celcuity's financial results?

The webcast will take place at 4:30 p.m. Eastern Time on August 14, 2024.

How can I listen to the Celcuity teleconference?

Dial 1-800-717-1738 for domestic callers and 1-646-307-1865 for international callers.

Where can I access the live webcast for Celcuity's event?

The live webcast can be accessed at this link: https://viavid.webcasts.com/starthere.jsp?ei=1678191&tp_key=c55c86e8c3.

Will there be a replay of the Celcuity webcast?

Yes, a replay of the webcast will be available on the Celcuity website after the event.

ShareAdd on Google
Tags: CELC Viatris Investor Conferences Healthcare Celcuity financial results biotechnology oncology webcast
Last updated: Aug 7, 2024

Biotech snapshot

Cash runway
$754M liquidity · $18M/mo burn
~41 mo
Minimal dilution risk
Lead asset
GedatolisibPhase 3
Breast Cancer →

Catalyst track record

+27%
best trade around CELC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CELC.

See every catalyst's timing & PoA →